Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

Discovery of a Novel Series of Potent and Orally Bioavailable Phosphoinositide 3-Kinase γ Inhibitors

Journal Article · · Journal of Medicinal Chemistry
DOI:https://doi.org/10.1021/jm300403a· OSTI ID:1495458
 [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1] more »;  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1] « less
  1. Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States
+ Show Author Affiliations

Abstract not provided

Research Organization:
Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
Sponsoring Organization:
INDUSTRY
OSTI ID:
1495458
Journal Information:
Journal of Medicinal Chemistry, Journal Name: Journal of Medicinal Chemistry Journal Issue: 11 Vol. 55; ISSN 0022-2623
Publisher:
American Chemical Society (ACS)
Country of Publication:
United States
Language:
ENGLISH

Similar Records

Discovery of a Novel Series of Potent and Orally Bioavailable Phosphoinositide 3-Kinase [gamma] Inhibitors
Journal Article · Wed Sep 18 00:00:00 EDT 2013 · J. Med. Chem. · OSTI ID:1093490
Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors
Journal Article · Thu Feb 20 23:00:00 EST 2020 · Journal of Medicinal Chemistry · OSTI ID:1635033
Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT
Journal Article · Fri Jun 01 00:00:00 EDT 2018 · Bioorganic and Medicinal Chemistry Letters · OSTI ID:1474162

Related Subjects